CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 164 filers reported holding CARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $240,799 | -51.9% | 85,088 | -16.6% | 0.03% | -51.5% |
| Q1 2023 | $500,869 | +24.9% | 102,010 | +173.3% | 0.07% | +4.6% |
| Q4 2022 | $400,946 | +69.9% | 37,332 | +47.8% | 0.06% | +80.6% |
| Q3 2022 | $236,000 | -36.4% | 25,257 | -37.8% | 0.04% | +9.1% |
| Q2 2022 | $371,000 | -73.1% | 40,621 | -64.2% | 0.03% | -72.3% |
| Q1 2022 | $1,379,000 | +3.3% | 113,517 | +3.6% | 0.12% | +16.7% |
| Q4 2021 | $1,335,000 | -17.4% | 109,617 | +4.7% | 0.10% | -12.1% |
| Q3 2021 | $1,617,000 | +53.1% | 104,648 | +41.4% | 0.12% | +65.7% |
| Q2 2021 | $1,056,000 | -25.3% | 74,032 | +13.8% | 0.07% | -31.4% |
| Q1 2021 | $1,413,000 | +28.3% | 65,067 | -10.6% | 0.10% | +37.8% |
| Q4 2020 | $1,101,000 | +12.8% | 72,770 | -5.1% | 0.07% | +15.6% |
| Q3 2020 | $976,000 | -15.8% | 76,704 | +13.1% | 0.06% | -19.0% |
| Q2 2020 | $1,159,000 | – | 67,800 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |